| Chest CT in COVID-19 at the ED: validation of the COVID-19 reporting and data system (CO-RADS) and CT severity score: a prospective, multicenter, observational study AWE Lieveld, K Azijli, BP Teunissen, RM van Haaften, RS Kootte, ... Chest 159 (3), 1126-1135, 2021 | 123 | 2021 |
| How we evaluate postgraduate medical e-learning: systematic review R De Leeuw, A De Soet, S Van Der Horst, K Walsh, M Westerman, ... JMIR medical education 5 (1), e13128, 2019 | 62 | 2019 |
| Digital vs face‐to‐face information provision in patient counselling for prenatal screening: A noninferiority randomized controlled trial RA de Leeuw, SFB van der Horst, AM de Soet, JP van Hensbergen, ... Prenatal diagnosis 39 (6), 456-463, 2019 | 18 | 2019 |
| Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes SFB van der Horst, ESL Martens, PL den Exter, MHA Bos, TE van Mens, ... Thrombosis research 228, 21-32, 2023 | 8 | 2023 |
| Inappropriate prescriptions of direct oral anticoagulants (DOACs) in hospitalized patients: A narrative review SFB van der Horst, N van Rein, TE van Mens, MV Huisman, FA Klok Thrombosis research 231, 135-140, 2023 | 4 | 2023 |
| Predicting poor outcome in patients with suspected COVID-19 presenting to the Emergency Department (COVERED)-Development, internal and external validation of a prediction model. K Azijli, A Lieveld, S van der Horst, N de Graaf, RS Kootte, MW Heijmans, ... ACUTE AND CRITICAL CARE DIAGN STICS IN COV D-19, 63, 2021 | 4 | 2021 |
| Prevalence and predictors of nonadherence to direct oral anticoagulant treatment in patients with atrial fibrillation SFB van der Horst, TAC de Vries, G Chu, R Bavalia, H Xiong, ... TH Open 7 (03), e270-e279, 2023 | 2 | 2023 |
| Performance of Risk Scores in Predicting Major Bleeding in Left Ventricular Assist Device (LVAD) Recipients: a Comparative External Validation SFB van der Horst, Y de Jong, N van Rein, JW Jukema, M Palmen, ... Research and Practice in Thrombosis and Haemostasis, 102437, 2024 | | 2024 |
| Sex differences at diagnosis and in one-year outcomes in patients with early atrial fibrillation EM Trinks-Roerdink, J Seelig, G Chu, SFB Van Der Horst, L Voorhout, ... BALANCING RISKS IN THROMBOEMBOLIC DISEASE, 85, 2024 | | 2024 |
| PB0699 Idarucizumab for Dabigatran Reversal: A Systematic Review and Meta-Analysis of Indications and Outcomes S van der Horst, E Martens, P den Exter, M Bos, M Huisman, E Klok Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| OC 74.4 Prevalence and Predictors of Non-Adherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation, a Historical Cohort Study S van der Horst, T de Vries, G Chu, R Bavalia, H Xiong, K van de Wiel, ... Research and Practice in Thrombosis and Haemostasis 7, 2023 | | 2023 |
| AWE Lieveld*, K Azijli*, BP Teunissen, RM van Haa en, RS Koo e, IAH van den Berk SFB van der Horst, C de Gans, PM van de Ven, PWB Nanayakkara ACUTE AND CRITICAL CARE DIAGN STICS IN COV D-19, 29, 0 | | |
